Comments
This is a new case of myeloproliferative neoplasm with dic(1;15). Although the histological bone marrow findings were compatible with essential thrombocythaemia and no other morphological aspects were suggestive of myelodysplastic syndrome, we could not rule out the potential impact of the previous treatment with Myleran in the genesis of the chromosomal abnormality. To our knowledge, there are 13 cases of dic(1;15) described in myeloid disorders: 7 in myeloprofiferative neoplasms (polycythaemia vera, essential thrombocythaemia and atypical myeloproliferative disorder), 4 in myelodysplastic syndromes and 2 in acute myeloid leukemia. Four of these cases were described by Theisen et al. in this cytogenetic atlas. In 3 of them, the survival was superior to 10 years and in only one case the death was related to disease progression.
